Retractable Technologies (NYSE:RVP) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVPFree Report) in a report released on Thursday. The firm issued a hold rating on the stock.

Retractable Technologies Stock Performance

Shares of RVP opened at $0.76 on Thursday. The company has a market capitalization of $22.72 million, a PE ratio of -1.24 and a beta of 2.06. The company has a debt-to-equity ratio of 0.01, a current ratio of 9.51 and a quick ratio of 6.54. Retractable Technologies has a one year low of $0.71 and a one year high of $1.34. The company’s fifty day moving average price is $0.89 and its 200 day moving average price is $1.03.

Retractable Technologies (NYSE:RVPGet Free Report) last released its earnings results on Wednesday, August 14th. The company reported ($0.48) earnings per share (EPS) for the quarter. Retractable Technologies had a negative net margin of 46.72% and a negative return on equity of 18.67%. The business had revenue of $6.03 million during the quarter.

Insiders Place Their Bets

In related news, CEO Thomas J. Shaw bought 71,422 shares of Retractable Technologies stock in a transaction that occurred on Friday, September 20th. The stock was acquired at an average price of $0.82 per share, for a total transaction of $58,566.04. Following the completion of the purchase, the chief executive officer now owns 14,743,907 shares in the company, valued at approximately $12,090,003.74. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders have purchased 182,037 shares of company stock worth $166,461 in the last ninety days. Insiders own 55.00% of the company’s stock.

Retractable Technologies Company Profile

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

Recommended Stories

Receive News & Ratings for Retractable Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies and related companies with MarketBeat.com's FREE daily email newsletter.